查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946596

2026年全球神经调控市场报告

Neuromodulation Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经调控市场发展迅速，预计将从2025年的76.2亿美元成长到2026年的84.5亿美元，复合年增长率达10.9%。过去几年的成长可归因于多种因素，例如慢性疼痛疾病盛行率的上升、神经系统疾病发生率的增加、微创疗法的接受度不断提高、专业疼痛管理中心的扩张以及先进植入式医疗设备的广泛应用。

预计未来几年神经调控市场将快速成长，到2030年市场规模将达到128.8亿美元，复合年增长率（CAGR）为11.1%。预测期内的成长要素包括：人工智慧辅助神经调控系统的日益普及、家庭神经调控疗法需求的成长、精神和神经系统疾病适应症的扩大、对患者个体化刺激通讯协定的日益重视，以及生物材料技术和设备小型化的持续进步。预测期内的主要趋势包括：植入式神经调控设备的日益普及、非侵入性神经调控疗法的广泛应用、智慧可程式设计刺激器的日益整合、神经调控应用领域从疼痛治疗扩展到其他领域，以及对个人化神经疗法的日益关注。

预计未来几年，医疗费用支出的成长将推动神经调控市场的发展。医疗费用支出是指分配给医疗保健及相关活动的总资金，包括医疗服务提供、公共和私人医疗保险、健康研究以及公共卫生项目。支出的成长将支持神经系统疾病新治疗方法和诊断方法的开发和应用，并为创新神经调控技术的研究和开发提供额外资金，从而提高其疗效、安全性和标靶化能力。例如，根据美国医疗保险和医疗补助服务中心（CMS）的数据，截至2025年6月，美国医疗费用支出将成长7.5%，到2023年达到4.9兆美元（人均14,570美元），相当于美国国内生产总值（GDP）的17.6%。因此，医疗费用支出的成长正在推动神经调控市场的发展。

神经调控领域的主要企业正优先研发下一代解决方案，以提高治疗精准度、改善病患舒适度并增强自身竞争力。这些解决方案包括先进的植入式脉衝产生器（IPG）。 IPG 是一种小型电池供电设备，通常皮下植入胸部或腹部，用于输送可控电刺激以治疗神经系统疾病。持续的技术创新致力于实现更个人化的治疗、延长电池寿命并简化植入手术。例如，2023 年 7 月，波士顿科学公司（Boston Scientific）的 Vercise Neural Navigator 5 软体及其搭载的 STIMVIEW XT 技术获得美国食品药物管理局（FDA）核准，可与第四代 Vercise Genus 深部食品药物管理局刺激系统配合使用。此解决方案可相容于可充电和不可充电的 IPG（植入式脉衝产生器），并支援五种磁振造影相容型 IPG，从而为帕金森氏症和自发性震颤患者提供更广泛的个人化深部脑部刺激治疗。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球神经调控市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧与自主智能
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 植入式神经调控设备的应用日益普及
    • 非侵入性神经调控疗法的应用日益增多
    • 智慧型可程式设计刺激器的整合正在推进
    • 将神经调控技术的应用范围扩展到疼痛以外的领域。
    • 人们越来越关注个人化神经疗法

第五章 终端用户产业市场分析

  • 医院
  • 专科诊所
  • 疼痛管理中心
  • 神经科诊所
  • 居家医疗保健服务提供者

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球神经调控市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球神经调控市场规模、对比及成长率分析
  • 全球神经调控市场表现：规模与成长，2020-2025年
  • 全球神经调控市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过技术
  • 体内神经调控，体外神经调控（非侵入性）
  • 透过生物材料
  • 聚合物生物材料、金属生物材料、陶瓷生物材料
  • 透过使用
  • 慢性疼痛、尿失禁和粪便失禁、偏头痛、脊椎手术后症候群、巴金森氏症、癫痫、震颤、忧郁症
  • 最终用户
  • 医院、诊所、居家医疗和其他应用
  • 依类型细分：体内神经调控
  • 植入式装置，鞘内药物传输系统
  • 按类型细分：外部神经调控（非侵入性）
  • 经颅磁刺激（TMS）、经颅直流电刺激（tDCS）、经皮神经电刺激（TENS）、週边神经刺激（PNS）

第十章 区域与国家分析

  • 全球神经调控市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球神经调控市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 神经调控市场：竞争格局及市场占有率（2024年）
  • 神经调控市场：公司估值矩阵
  • 神经调控市场：公司概况
    • Abbott Laboratories
    • Soterix Medical Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Synapse Biomedical Inc.

第37章：其他领先和创新企业

  • Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics SA, Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年神经调控市场：提供新机会的国家
  • 2030年神经调控市场：新兴细分市场机会
  • 2030年神经调控市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MNEUR04_G26Q1

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

Tariffs are impacting the neuromodulation market by increasing costs of imported electronic components, implantable biomaterials, microcontrollers, stimulation leads, and precision manufacturing equipment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-tech implants, while Asia-Pacific faces higher costs in device exports. These tariffs are increasing treatment costs and slowing adoption rates. However, they are also encouraging domestic production, localized component sourcing, and innovation in cost-efficient neuromodulation device designs.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including neuromodulation industry global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown rapidly in recent years. It will grow from $7.62 billion in 2025 to $8.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, growing incidence of neurological disorders, increased acceptance of minimally invasive therapies, expansion of specialized pain management centers, availability of advanced implantable devices.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $12.88 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted neuromodulation systems, rising demand for home-based neuromodulation therapies, expansion of indications in psychiatric and neurological disorders, growing focus on patient-specific stimulation protocols, continuous technological advancements in biomaterials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of non-invasive neuromodulation therapies, growing integration of smart and programmable stimulators, expansion of neuromodulation applications beyond pain, enhanced focus on personalized neurotherapy.

Increasing healthcare expenditures are projected to drive the growth of the neuromodulation market in the coming years. Healthcare expenditure encompasses the total funds allocated for health care and related activities, including health services provision, public and private health insurance, health research, and public health initiatives. Rising expenditures support the development and adoption of new therapies and diagnostic methods for neurological disorders, and they also provide additional funding for research into innovative neuromodulation technologies, enhancing their efficacy, safety, and targeting capabilities. For example, in June 2025, according to the Centers for Medicare & Medicaid Services, national health expenditures in 2023 increased by 7.5% to reach $4.9 trillion, or $14,570 per capita, representing 17.6% of the United States gross domestic product. Thus, the rising healthcare expenditure is fueling the growth of the neuromodulation market.

Leading players in the neuromodulation sector are prioritizing the development of next-generation solutions, including advanced implantable pulse generators (IPGs), to enhance therapeutic accuracy, improve patient comfort, and strengthen their competitive positioning. An IPG is a small, battery-powered device implanted beneath the skin commonly in the chest or abdominal area, that delivers controlled electrical stimulation to treat neurological disorders. Ongoing innovations focus on enabling greater personalization, extending battery life, and simplifying implantation procedures. For instance, in July 2023, Boston Scientific Corporation received approval from the U.S. Food and Drug Administration for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, intended for use with the fourth-generation Vercise Genus Deep Brain Stimulation system. The solution supports both rechargeable and non-rechargeable IPGs and accommodates five magnetic resonance-conditional implantable pulse generators, providing a broad range of options to personalize deep brain stimulation therapy for patients with Parkinson's disease or essential tremor.

In December 2024, electroCore Inc., a United States-based bioelectronic medicine company, completed the acquisition of NeuroMetrix Inc. for an undisclosed consideration. Through this transaction, electroCore seeks to strengthen its wearable neuromodulation offerings for chronic pain by incorporating NeuroMetrix's Quell(R) platform and broadening its portfolio of non-invasive bioelectronic therapies. NeuroMetrix Inc. specializes in the development of wearable neuromodulation solutions designed to address chronic pain management.

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuromodulation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuromodulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
  • 2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
  • 3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
  • 4) By End-User: Hospitals; Clinics; Home Healthcare
  • Subsegments:
  • 1) By Internal Neuromodulation: Implantable Devices; Intrathecal Drug Delivery Systems
  • 2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS); Transcranial Direct Current Stimulation (tDCS); Transcutaneous Electrical Nerve Stimulation (TENS); Peripheral Nerve Stimulation (PNS)
  • Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.; Nevro Corp; NeuroPace Inc.; LivaNova PLC; NeuroSigma Inc.; Neuronetics Inc.; Bioness Inc.; Aleva Neurotherapeutics S.A.; Integer Holdings Corporation; Inspire Medical Systems Inc.; Saluda Medical Pty Ltd; Inbrain Neuroelectronics SAS; Pixium Vision SA; Neuromod Devices Limited; Cognito Therapeutics Inc.; PathMaker Neurosystems Inc.; Dignify Therapeutics Inc.; Neuros Medical Inc.; Koninklijke Philips N.V.; Omron Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neuromodulation Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neuromodulation Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neuromodulation Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neuromodulation Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Implantable Neuromodulation Devices
    • 4.2.2 Rising Use Of Non-Invasive Neuromodulation Therapies
    • 4.2.3 Growing Integration Of Smart And Programmable Stimulators
    • 4.2.4 Expansion Of Neuromodulation Applications Beyond Pain
    • 4.2.5 Enhanced Focus On Personalized Neurotherapy

5. Neuromodulation Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Pain Management Centers
  • 5.4 Neurology Clinics
  • 5.5 Home Healthcare Providers

6. Neuromodulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuromodulation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neuromodulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neuromodulation Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neuromodulation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neuromodulation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuromodulation Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuromodulation Market Segmentation

  • 9.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Internal Neuromodulation, External Neuromodulation (Non-invasive)
  • 9.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
  • 9.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression
  • 9.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Home Healthcare, Other Applications
  • 9.5. Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Devices, Intrathecal Drug Delivery Systems
  • 9.6. Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

10. Neuromodulation Market Regional And Country Analysis

  • 10.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuromodulation Market

  • 11.1. Asia-Pacific Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuromodulation Market

  • 12.1. China Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuromodulation Market

  • 13.1. India Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuromodulation Market

  • 14.1. Japan Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuromodulation Market

  • 15.1. Australia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuromodulation Market

  • 16.1. Indonesia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuromodulation Market

  • 17.1. South Korea Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuromodulation Market

  • 18.1. Taiwan Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuromodulation Market

  • 19.1. South East Asia Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuromodulation Market

  • 20.1. Western Europe Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuromodulation Market

  • 21.1. UK Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuromodulation Market

  • 22.1. Germany Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuromodulation Market

  • 23.1. France Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuromodulation Market

  • 24.1. Italy Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuromodulation Market

  • 25.1. Spain Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuromodulation Market

  • 26.1. Eastern Europe Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuromodulation Market

  • 27.1. Russia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuromodulation Market

  • 28.1. North America Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuromodulation Market

  • 29.1. USA Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuromodulation Market

  • 30.1. Canada Neuromodulation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuromodulation Market

  • 31.1. South America Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuromodulation Market

  • 32.1. Brazil Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuromodulation Market

  • 33.1. Middle East Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuromodulation Market

  • 34.1. Africa Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuromodulation Market Regulatory and Investment Landscape

36. Neuromodulation Market Competitive Landscape And Company Profiles

  • 36.1. Neuromodulation Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neuromodulation Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neuromodulation Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Soterix Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Synapse Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neuromodulation Market Other Major And Innovative Companies

  • Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc.

38. Global Neuromodulation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuromodulation Market

40. Neuromodulation Market High Potential Countries, Segments and Strategies

  • 40.1 Neuromodulation Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neuromodulation Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neuromodulation Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer